John MBA - Achieve Life CEO Director

Achieve Life Management Efficiency

The company has return on total asset (ROA) of (0.5409) % which means that it has lost $0.5409 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8604) %, meaning that it created substantial loss on money invested by shareholders. Achieve Life's management efficiency ratios could be used to measure how well Achieve Life manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Achieve Life's Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to climb to 21.62 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (1.65). At this time, Achieve Life's Non Currrent Assets Other are fairly stable compared to the past year. Intangibles To Total Assets is likely to climb to 0.12 in 2024, whereas Non Current Assets Total are likely to drop slightly above 2.2 M in 2024.

Similar Executives

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. It has license agreements with Sopharma AD and University of Bristol. Achieve Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people. Achieve Life Sciences (ACHV) is traded on NASDAQ Exchange in USA. It is located in 1040 West Georgia Street, Vancouver, BC, Canada, V6E 4H1 and employs 22 people. Achieve Life is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Achieve Life Sciences Leadership Team

Achieve Stock Performance Indicators

Additional Tools for Achieve Stock Analysis